P/E at 59.17 vs Industry's 65.76: What the Data Shows for Apollo Hospitals Enterprise Ltd.

Valuation Picture: Discount Amidst Sector Premiums

Apollo Hospitals Enterprise Ltd. trades at a P/E multiple of 59.17, which is approximately 10% below the hospital industry average of 65.76. This discount is intriguing given the company’s stature as a large-cap with a market capitalisation of ₹1,23,819.44 crores. Typically, such a premium sector P/E reflects strong growth expectations or superior profitability, yet Apollo Hospitals appears to be valued more conservatively relative to its peers. This valuation gap raises questions about whether the market is pricing in near-term headwinds or a recalibration of growth prospects — previously rated Strong Buy, what is Apollo Hospitals’ current rating?

Performance Across Timeframes: Mixed Momentum Signals

Examining returns across multiple horizons reveals a divergence in momentum. Over the past year, Apollo Hospitals has delivered a respectable 8.69% gain, outperforming the Sensex which declined by 4.35% during the same period. The year-to-date performance is even more striking, with the stock up 22.28% compared to the Sensex’s 8.75% loss. However, the shorter-term picture is less favourable. The stock has declined 2.19% over the last month and 2.87% in the past week, underperforming the Sensex’s modest gains of 2.25% and 0.05% respectively. The three-month return of 3.01% slightly trails the Sensex’s 3.12% rise, signalling a recent loss of relative strength. This pattern suggests that while the stock has demonstrated resilience over longer periods, recent market dynamics have weighed on its momentum — is this a temporary correction or a sign of deeper weakness?

Moving Average Configuration: Signs of a Complex Trend

The technical setup of Apollo Hospitals offers further insight into its current trajectory. The stock price is positioned above its 100-day and 200-day moving averages, indicating that the longer-term trend remains intact. However, it trades below the 5-day, 20-day, and 50-day moving averages, reflecting short-term pressure and a recent pullback. This configuration often points to a consolidation phase or a corrective pause within a broader uptrend. Notably, the stock has just ended a five-day losing streak with a slight gain, suggesting potential stabilisation. The 5% surge partially reverses a 6.45% monthly decline — is this a genuine recovery or a relief rally that will fade at the 50 DMA? — the moving average configuration provides the clearest answer.

Sector Performance Context: Hospital Industry Trends

The hospital sector has experienced mixed results recently, with a blend of positive, flat, and negative performances across constituent stocks. The industry P/E of 65.76 reflects elevated expectations, driven by ongoing demand for healthcare services and innovation in medical technology. Within this environment, Apollo Hospitals’ valuation discount and recent momentum challenges stand out. The sector’s overall resilience contrasts with the stock’s short-term softness, suggesting company-specific factors may be influencing investor sentiment. This divergence invites further scrutiny — how does the sector’s mixed performance affect Apollo Hospitals’ outlook?

Rating Reassessment: From Strong Buy to Updated View

On 20 Aug 2026, the rating for Apollo Hospitals Enterprise Ltd. was updated from a previous Strong Buy to a new assessment. The Mojo Score currently stands at 77.0, reflecting a solid but more measured stance. This change aligns with the valuation discount and the recent performance divergence, signalling a recalibration of expectations. The rating update underscores the importance of balancing the company’s long-term strengths against short-term headwinds — should investors in Apollo Hospitals hold, buy more, or reconsider?

Long-Term Performance: A Strong Track Record

Despite recent short-term fluctuations, Apollo Hospitals boasts impressive long-term returns. Over three years, the stock has surged 75.07%, significantly outperforming the Sensex’s 19.18% gain. The five-year return of 77.81% also dwarfs the Sensex’s 38.97%, while the ten-year performance is particularly remarkable at 533.75%, compared to the Sensex’s 177.15%. These figures highlight the company’s sustained growth and resilience over a decade, reinforcing its status as a leading player in the hospital sector. The contrast between this long-term strength and recent short-term softness invites reflection on the stock’s current valuation and momentum — is the recent weakness a buying opportunity or a warning sign?

Intraday and Recent Trading Dynamics

On 24 Aug 2026, Apollo Hospitals opened at ₹8,749.6 and traded at this level throughout the day, closing with a modest decline of 0.55%. This performance slightly outpaced the hospital sector’s average, which saw a 0.5% outperformance today. The stock’s recent gain after a five-day losing streak suggests some short-term buying interest, although it remains below its short-term moving averages. This intraday stability amid broader sector volatility adds another layer to the stock’s complex technical picture.

Conclusion: Valuation and Momentum in Balance

The data on Apollo Hospitals Enterprise Ltd. reveals a nuanced story. The stock trades at a meaningful discount to its sector’s lofty P/E, despite a strong long-term performance record. Short-term momentum has softened, reflected in recent underperformance relative to the Sensex and a mixed moving average configuration. The rating update from Strong Buy to a more tempered view aligns with these signals, emphasising the need for investors to weigh valuation against evolving market dynamics carefully. What does the current rating mean for shareholders navigating this valuation-performance tension?

Only Rs. 9,999 - Get MojoOne + Stock of the Week for 1 Year Start at 33% Off →